filmov
tv
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says
Показать описание
The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer said in a news release.
FDA approves new nasal spray for emergency allergic reactions
FDA approves new nasal spray to treat migraine headaches
FDA approves new nasal spray for migraines
FDA approves first nasal spray to treat severe allergic reaction
FDA approves new nasal spray medication for depression
FDA approves new nasal spray for migraines
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says
FDA approves new nasal spray for migraines
FDA approves at-home nasal spray flu vaccine for 2025 release
FDA approves new nasal spray alternative to traditional EpiPen
FDA approves a new nasal spray that can help treat allergic reactions
FDA approves nasal spray for migraines
FDA approves new nasal spray to treat potentially life-threatening allergic reactions
FDA approves first nasal spray for treatment of anaphylaxis
Ask Dr. Nandi: FDA approves ketamine-like nasal spray for depression
FDA approves nasal spray to treat migraines
FDA approves nasal spray antidepressant
FDA approves nasal spray to treat allergic reactions
New nasal spray to treat potentially life-threatening allergic reactions approved by FDA
Nasal spray to treat depression
FDA approves nasal spray for migraines
Health News 18: FDA Approves 1st Nasal Spray Epinephrine Drug
A closer look: New nasal spray approved by FDA reverses opioid overdoses
Depression nasal spray acts fast, patients thrilled with results
Комментарии